Unlocking Myasthenia Gravis Efficacy: Navigating Advanced Outcome Measures in Clinical Trials

Delve into the complexities of Myasthenia Gravis (MG), a heterogeneous neuromuscular disorder, and explore the evolution of standardized clinical scales and questionnaires used as outcome measures in clinical trials. Understand the shift from objective assessments to patient-reported outcomes (PROs), including key scales like QMG, MG-ADL, MGC, and QOL15(r)